A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the duration of T reg suppression in patients with
metastatic pancreatic cancer receiving Ontak. The goal is to define the optimal time for
future dendritic cell vaccine administration.